S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5202 Reports
🤖 AI Analyzed
Recent
📄 Page 57 of 434
Photozou Holdings, Inc.
10-K March 30, 2026

Key Highlights

  • Pivot to high-growth 'short drama' mobile video app launching in 2026
  • Leveraging existing 2.5 million registered user base for cross-platform monetiza...
  • Aggressive operational restructuring to minimize overhead and focus on digital c...
Read Analysis
🤖 AI Generated
Avalon GloboCare Corp.
10-K March 30, 2026

Key Highlights

  • Strategic pivot from medical research to the high-growth AI creator economy.
  • Acquisition of RPM Interactive for $19.5 million to launch a generative AI platf...
  • Significant cost-cutting measures, including ending China operations and canceli...
Read Analysis
🤖 AI Generated
zSpace, Inc.
10-K March 30, 2026

Key Highlights

  • Widespread adoption in over 3,500 U.S. school districts, including 80% of the to...
  • Established international presence in over 50 countries, providing revenue diver...
  • Strategic pivot underway to transition from hardware-heavy to a software-only su...
Read Analysis
🤖 AI Generated
AVENUE THERAPEUTICS, INC.
10-K March 30, 2026

Key Highlights

  • Divested Baergic Bio subsidiary for $10 million to streamline focus on AJ201
  • Strategic pivot to prioritize AJ201 for spinal and bulbar muscular atrophy
  • Raised $8.5 million in 2025 to extend operational runway
Read Analysis
🤖 AI Generated
Ondas Inc.
10-K March 30, 2026

Key Highlights

  • Revenue surged to $17.5 million, a significant increase from $3.2 million in 202...
  • Transitioned to a 'Systems-of-Systems' model, bundling drones, software, and mai...
  • Secured multi-year partnerships with major industrial and government clients, in...
Read Analysis
🤖 AI Generated
Myseum, Inc.
10-K March 30, 2026

Key Highlights

  • Focus on privacy-first social media with 'nukeable' messaging technology.
  • Strong intellectual property portfolio featuring 20 encryption and data storage ...
  • Significant reduction in operating losses through cost-cutting and divestment of...
Read Analysis
🤖 AI Generated
Laird Superfood, Inc.
10-K March 30, 2026

Key Highlights

  • Acquired Navitas Organics for $38.5 million to scale operations and expand produ...
  • Achieved 12% year-over-year revenue growth, reaching $42.6 million in 2025.
  • Established a strong subscription business model, which currently accounts for 3...
Read Analysis
🤖 AI Generated
HYPERION DEFI, INC.
10-K March 30, 2026

Key Highlights

  • Successful pivot from medical-tech to a hybrid crypto-validator model.
  • Operates a significant validator node, 'Kinetiq x Hyperion', with over 11 millio...
  • Launching 'HYPE-as-a-service' to generate institutional management fees independ...
Read Analysis
🤖 AI Generated
Cottonwood Communities, Inc.
10-K March 30, 2026

Key Highlights

  • Large-scale portfolio of 37 apartment communities totaling 11,248 units.
  • Strategic focus on high-growth Sun Belt markets to drive long-term value.
  • Consistent revenue growth, reaching $284.5 million in 2025.
Read Analysis
🤖 AI Generated
CD 2017-CD3 Mortgage Trust
10-K March 30, 2026

Key Highlights

  • Diversified portfolio of 56 commercial real estate loans across office, retail, ...
  • Consistent track record of meeting all required investor payments.
  • Risk mitigation through a structure where no single loan exceeds 20% of the tota...
Read Analysis
🤖 AI Generated
Virgin Galactic Holdings, Inc
10-K March 30, 2026

Key Highlights

  • Successful completion of six commercial flights in six months during 2024.
  • Development of the Delta Class fleet, designed to carry six passengers per fligh...
  • Scalable business model targeting up to 125 flights per year with new ships.
Read Analysis
🤖 AI Generated
Inmune Bio, Inc.
10-K March 30, 2026

Key Highlights

  • Lead drug CORDStrom showed safety and efficacy in Phase 2 trials for RDEB.
  • Targeting regulatory filings for CORDStrom in the UK, EU, and U.S. by late 2026.
  • FDA granted CORDStrom 'Orphan Drug' status, providing tax credits and 7-year mar...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage